<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of Prader-Willi syndrome</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of Prader-Willi syndrome</h1>
<div class="graphic"><div class="figure"><div class="ttl">Management of Prader-Willi syndrome</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Characteristics and monitoring</td> <td class="subtitle1">Interventions</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Feeding and obesity</td> </tr> <tr> <td class="indent1">Infants</td> <td> <ul> <li>Feeding problems, poor weight gain, lack of interest in feeding</li> </ul> </td> <td> <ul> <li>Oromotor therapy</li> <li>Concentrated feeds (consult dietitian); commonly, nasogastric supplemental feeds</li> </ul> </td> </tr> <tr> <td class="indent1">Children and adults</td> <td> <ul> <li>Hyperphagia, obesity when there is a lack of environmental control</li> </ul> </td> <td> <ul> <li>Food restriction (with physical barriers) at home and school</li> <li>Calorie-restricted diet/low-carbohydrate diet; consult dietitian</li> <li>Exercise/physical therapy</li> <li>Consider pharmacotherapy if above actions are not effective</li> <li>Refer/discuss management of challenging cases with a PWS center</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Behavior and neurodevelopment</td> </tr> <tr> <td class="indent1">Motor skills</td> <td> </td> <td> <ul> <li>Early intervention, occupational therapy, rhGH</li> <li>Carnitine supplements if deficient</li> </ul> </td> </tr> <tr> <td class="indent1">Behavioral rigidity, obsessive-compulsive behaviors</td> <td> </td> <td> <ul> <li>Behavioral specialist</li> <li>Pharmacotherapy</li> </ul> </td> </tr> <tr> <td class="indent1">Skin picking</td> <td> </td> <td> <ul> <li>Possible options: <ul> <li>N-acetylcysteine</li> <li>Guanfacine</li> <li>Topiramate</li> </ul> </li> </ul> </td> </tr> <tr> <td class="indent1">Anxiety</td> <td> </td> <td> <ul> <li>Behavioral therapy</li> <li>Pharmacotherapy (use with caution due to risk of activation)</li> </ul> </td> </tr> <tr> <td class="indent1">Cognitive and learning deficits</td> <td> <ul> <li>Mild or moderate intellectual disability (mean IQ 60)</li> </ul> </td> <td> <ul> <li>Early intervention therapies (occupational therapy, physical therapy)</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Endocrine issues</td> </tr> <tr> <td class="indent1">Growth hormone deficiency</td> <td> <ul> <li>rhGH improves linear growth, body composition, bone density, physical function, and motor development; in young children, it may promote cognitive development</li> </ul> </td> <td> <ul> <li>Initiate shortly after diagnosis of PWS (if nutrition is adequate)</li> <li>Benefits children and adults, with or without growth hormone deficiency</li> <li>Monitor for respiratory complications and hyperglycemia before and during therapy</li> <li>Monitor for development or worsening of scoliosis (children)</li> </ul> </td> </tr> <tr> <td class="indent1">Hypogonadism</td> <td> <ul> <li>Cryptorchidism</li> <li>Pubertal delay</li> <li>Infertility</li> </ul> </td> <td> <ul> <li>hCG (3 to 18 months old)</li> <li>Orchiopexy if needed</li> <li>Treatment for hypogonadism as needed*</li> <li>Birth control pills for fertile women</li> </ul> </td> </tr> <tr> <td class="indent1">Low bone mineral density and osteoporosis</td> <td> <ul> <li>DXA every 2 to 3 years beginning in late childhood</li> </ul> </td> <td> <ul> <li>Dietary calcium and vitamin D</li> <li>Sex steroid replacement*</li> <li>rhGH treatment</li> <li>For osteoporosis, consider treatment with bone resorption inhibitors in adults</li> </ul> </td> </tr> <tr> <td class="indent1">Hypothyroidism</td> <td> <ul> <li>Measure fT4 (to detect central hypothyroidism) and TSH (to diagnose primary hypothyroidism)</li> <li>Monitor every few months during the first year of life, then annually thereafter</li> </ul> </td> <td> <ul> <li>Management is similar to other patients with central hypothyroidism<sup>¶</sup></li> </ul> </td> </tr> <tr> <td class="indent1">Central adrenal insufficiency</td> <td> <ul> <li>Association with PWS is not established</li> <li>Test if symptoms develop (unexplained nausea, vomiting, or hypotension, especially during physical stress)</li> </ul> </td> <td> <ul> <li>Management is similar to other patients with hypocortisolism<sup>¶</sup></li> </ul> </td> </tr> <tr> <td class="indent1">Type 2 diabetes mellitus</td> <td> <ul> <li>Test with fasting blood glucose, hemoglobin A1c</li> <li>Test annually in patients with obesity</li> </ul> </td> <td> <ul> <li>Food security and physical activity are essential to management</li> <li>Management is otherwise similar to other patients with type 2 diabetes<sup>¶</sup><sup>Δ</sup></li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Sleep disorders</td> </tr> <tr> <td class="indent1">Sleep apnea</td> <td> <ul> <li>Mostly obstructive but may have central component</li> <li>Monitor for sleep-related symptoms</li> <li>PSG is indicated after start of growth hormone, at age 3 years, and if there is significant weight gain or change in behavior</li> </ul> </td> <td> <ul> <li>Adenotonsillectomy</li> <li>Residual symptoms are common</li> <li>CPAP may help but may be a challenge to implement, requiring behavioral intervention</li> <li>Tracheostomy in refractory cases</li> </ul> </td> </tr> <tr> <td class="indent1">Excessive daytime sleepiness</td> <td> <ul> <li>Primary disorder of vigilance</li> </ul> </td> <td> <ul> <li>Possible options: <ul> <li>Modafinil</li> <li>Pitolisant</li> </ul> </li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Orthopedic problems</td> </tr> <tr> <td class="indent1">Scoliosis</td> <td> <ul> <li>Clinical evaluation throughout growth</li> <li>Spine radiograph every 1 to 2 years, beginning at approximately 6 years</li> </ul> </td> <td> <ul> <li>Evaluation by an orthopedic specialist if scoliosis is detected</li> </ul> </td> </tr> <tr> <td class="indent1">Hip dysplasia</td> <td> </td> <td> <ul> <li>Hip ultrasound (infants); frequency is not established</li> </ul> </td> </tr> <tr> <td class="indent1">Lower limb alignment abnormalities</td> <td> </td> <td> <ul> <li>Footwear technician</li> <li>Orthopedic specialist</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>PWS: Prader-Willi syndrome; rhGH: recombinant human growth hormone; IQ: intelligence quotient; hCG: human chorionic gonadotropin; DXA: dual-energy x-ray absorptiometry; fT4: free thyroxine; TSH: thyroid-stimulating hormone; PSG: polysomnography (sleep study); CPAP: continuous positive airway pressure; GLP-1 RA: glucagon-like peptide 1 receptor agonist.</p>
<p>* Initiation and dosing of sex hormone therapy should be made in consultation with an endocrinologist. Considerations include benefits on bone density and potential adverse effects of sex hormones on mood, behavior, and epiphyseal closure.</p>
<p>¶ Refer to appropriate UpToDate content.</p>
Δ For individuals with PWS, food security is essential. The efficacy and safety of GLP-1 RA in this population has not been established.</div><div class="graphic_reference">References:
    <ol>
<li>McCandless SE, Committee on Genetics. Clinical report – health supervision for children with Prader-Willi syndrome. Pediatrics 2011; 127:195.</li>
<li>Duis J, van Wattum PJ, Scheimann A, et al. A multidisciplinary approach to the clinical management of Prader-Willi syndrome. Mol Genet Genomic Med 2019; 7:e514.</li>
<li>Butler MG, Miller JL, Forster JL, et al. Prader-Willi Syndrome – Clinical Genetics, Diagnosis and Treatment Approaches: An Update. Curr Pediatr Rev 2019; 15:207.</li>
<li>Duis J, Pullen LC, Picone M, et al. Diagnosis and management of sleep disorders in Prader-Willi syndrome. J Clin Sleep Med 2022; 18:1687.</li>
</ol></div><div id="graphicVersion">Graphic 140076 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
